ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,021.63
0.57%
US Tech 100
20,367.60
0.51%
다우존스 지수
44,860.31
0.28%
Bitcoin
92,636.90
0.72%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE

  6. Genflow Biosciences Plc (GENF) 시세

Genflow Biosciences Plc

Genflow Biosciences Plc (GENF)

LSE
1.73
0.005
(0.29%)
마감 27 11월 1:30AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
1.73
매수가
1.55
매도가
1.70
거래량
2,133,983
1.625 일간 변동폭 1.725
1.35 52주 범위 3.30
market_cap
6.05M
전일 종가
1.725
개장가
1.725
최근 거래 시간
9697
@
1.73
(UT)
마지막 거래 시간
재정 규모
36,865p
VWAP
1.7275
평균 볼륨(3m)
639,867
발행 주식
349,706,618
배당수익률
-
주가수익률
-3.45
주당순이익(EPS)
-0
매출
169k
순이익
-1.63M

Genflow Biosciences Plc 정보

섹터
Coml Physical, Biologcl Resh
산업
Coml Physical, Biologcl Resh
웹사이트
www.genflowbio.com
본부
London, Gbr
설립됨
-
Genflow Biosciences Plc is listed in the Coml Physical, Biologcl Resh sector of the 런던증권거래소 with ticker GENF. The last closing price for Genflow Biosciences was 1.73p. Over the last year, Genflow Biosciences shares have traded in a share price range of 1.35p to 3.30p.

Genflow Biosciences currently has 349,706,618 shares in issue. The market capitalisation of Genflow Biosciences is £6.03 million. Genflow Biosciences has a price to earnings ratio (PE ratio) of -3.45.

GENF 최신 뉴스

추가 뉴스

Genflow Biosciences secures EUR4 million for liver disease treatment

Genflow Biosciences PLC on Tuesday said it has secured EUR4 million in funding from the Wallonia region in Belgium, t ...

22 10월 2024
Alliance News

Genflow Biosciences PLC Genflow Secures Non-Dilutive Financial Support

Genflow Biosciences PLC 22 October 2024     THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE...

22 10월 2024
RNS Regulatory News

Genflow Biosciences PLC Half-year Report

Genflow Biosciences PLC 30 September 2024   PRESS RELEASE   30 September 2024 Genflow Biosciences Plc   ("Genflow" or "the Company")   HALF YEAR RESULTS     Genflow (LSE: GENF) is pleased to...

30 9월 2024
RNS Regulatory News

Genflow Biosciences Plc to Present at the Life Sciences Investor Forum September 19th

LONDON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Genflow Biosciences Plc (LSE:GENF OTCQB:GENFF), based in the UK, focused on pioneering gene therapies to decelerate the aging process, today...

16 9월 2024
GlobeNewswire Inc.

EARNINGS AND TRADING: Shuka Minerals loss narrows; Atome loss widens

The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not se ...

28 6월 2024
Alliance News

Genflow Biosciences PLC Result of AGM

Genflow Biosciences PLC 27 June 2024     27 June 2024 Genflow Biosciences Plc Results of Annual General Meeting     Genflow Biosciences Plc (LSE:GENF) (OTCQB:GENFF) ("Genflow" or "the...

27 6월 2024
RNS Regulatory News

EARNINGS AND TRADING: Distil loss widens; Genflow welcomes grant

The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not s ...

13 6월 2024
Alliance News

Genflow Biosciences PLC Receipt of Grant Funding

Genflow Biosciences PLC 12 June 2024     THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE...

12 6월 2024
RNS Regulatory News

Genflow Biosciences PLC Notice of AGM

Genflow Biosciences PLC 03 June 2024     3 June 2024 Genflow Biosciences Plc Notice of Annual General Meeting Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an...

03 6월 2024
RNS Regulatory News

Genflow Biosciences receives 50% of grant for sarcopenia project

Genflow Biosciences PLC on Thursday said that it has received half of its grant funding from the Government of Wallon ...

30 5월 2024
Alliance News
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.07-3.888888888891.81.81.6256106371.7440346DE
4-0.07-3.888888888891.81.91.6253589801.77075267DE
12-0.52-23.11111111112.252.31.6256398671.92054911DE
26-0.97-35.92592592592.73.31.6256713852.38142513DE
52-0.07-3.888888888891.83.31.359361611.98833625DE
156-7.52-81.29729729739.2513.251.3510329002.95902582DE
260-7.52-81.29729729739.2513.251.3510329002.95902582DE

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ORCPOracle Power Plc
0.0305p
(158.47%)
6.24B
STKStreaksai Plc
0.35p
(59.09%)
8.58M
QEDQuadrise Plc
3.62p
(57.39%)
94.06M
ENWEnwell Energy Plc
23.00p
(46.03%)
160.81k
WEBWebis Holdings Plc
0.125p
(38.89%)
9.14M
INXI-nexus Global Plc
1.50p
(-52.38%)
7.25M
SFRSeverfield Plc
55.60p
(-36.24%)
9.71M
LENDSancus Lending Group Limited
0.30p
(-33.33%)
1.23M
TRYBTribe Technology Plc
2.45p
(-20.97%)
80k
GWMOGreat Western Mining Corporation Plc
0.0175p
(-20.45%)
169.92M
ORCPOracle Power Plc
0.0305p
(158.47%)
6.24B
NTVONativo Resources Plc
0.0025p
(0.00%)
3.46B
TRPTower Resources Plc
0.0275p
(0.00%)
526.88M
CPXCap-xx Limited
0.145p
(-13.43%)
499.92M
MSMNMosman Oil And Gas Limited
0.038p
(-1.30%)
329.43M

토론

전체 피드 보기
Plato_ Plato_ 9 분 전
https://investorshub.advfn.com/uimage/uploads/2024/11/27/hcolltrade-error-314217-the-share-quanitty-is-limited.png
Source: https://www.reddit.com/r/fidelityinvestments/comments/1grxuld/comment/ly9voew

FYI. Found this on a subreddit regarding Fidelity restrictions on trade size.
GDVM
gimmegimmeminemine gimmegimmeminemine 10 분 전
At a bare minimum, I want to see viable proof that they have solved the issue of mass scale production, cost effectively on a quality consistent basis.
Clear and consice viable proof.

I would be ecstatic if they are ready or already putting out product on a regular basis, be i
KBLB
rrflyboy rrflyboy 10 분 전
"Phunware Loss Causation Decision Dismissing The MTD With No Prejudice to Determining Still Longer Term Damage"
Thanks for the info dbing, finally a bit of sunshine may appear.
Same court, same issues, same law firm and the same plaintiff's attorney, Posner, as the NWBO case. Not sure
NWBO
jondoeuk jondoeuk 11 분 전
Big volume into the close, over 12 million. Someone knows something.
FATE
dinogreeves dinogreeves 11 분 전
Just Wow. Some reason I knew this was coming.

Now we wait to see this strategic move

Going private? Maybe, then why file for extension or even hire an auditor, was this a last minute decision?

Buyout offer on the table? Who knows

Merger
SMCI
XenaLives XenaLives 11 분 전
The short whores are out in force tonight.

It seems that capitulation of short interest is imminent....


HOLD..

HOLD....

HOLD .......


NOW !!!!!



https://www.youtube.com/watch?v
LWLG
jimmy051357 jimmy051357 11 분 전
Do you think the decision to set this up to transition on Dec 30 was an accident?
SANP
DJPele DJPele 12 분 전
https://x.com/hoffmann6383/status/1861618491058491410

Breaking News: Federal Court Allows Second Spoofing Case against Market Maker to Proceed

The Case: Phunware Inc. v. UBS Securities, LLC, 1:23-cv-06426 (SDNY)

Plaintiff: $PHUN
Defendant:
NWBO PHUN UBS
hardlesson hardlesson 13 분 전
You might not want to lump me in to "everyone." You had shares until today, when you flip flopped again over your fears of tax loss sellers.

Your playbook is cyclical, and predictable. See you in the morning with your amusing bid whacks, because we both know you've saved some.
SHMN
dinogreeves dinogreeves 14 분 전
"On November 20, 2024, Super Micro Computer, Inc. (the “Company”) prepaid in full and terminated its obligations under each of (i) the Loan Agreement, by and among the Company and Cathay Bank, as amended or otherwise modified, and (ii) the Loan and Security Agreement with Bank of America N.A., by an
SMCI
TrendTrade2016 TrendTrade2016 15 분 전
Another China monster and the clowns missed it as always
HSAI
TrendTrade2016 TrendTrade2016 17 분 전
KDLY beautiful run
KDLY
holter49 holter49 18 분 전
It has been a month and Patrick has been quiet. What does that say for the company performance?
MLRT
muee88 muee88 18 분 전
Interesting. The procedural history appears to be a lot different from our case. In PHUN, the defendant’s MTD was granted but the court allowed plaintiff to file a motion to amend their complaint. It seems that in granting this motion, the Court has also allowed the case to speed past another MTD op
PHUN
Kaiserwave Kaiserwave 18 분 전
Shares updated on OTCM
OTCM
TrendTrade2016 TrendTrade2016 19 분 전
MTEK next drone play… weekly breaking out.
MTEK
holter49 holter49 20 분 전
I do not discount what you said. I knew the field of play was not level. Just like a football field bows in the middle for drainage. Most people know their are sharks in the water.
NPHC
dinogreeves dinogreeves 20 분 전
Yes, I don't have shares, not going to feed into paid pumpers on this board nor dirty hicks. I just like to entertain myself every now and then, IHUB is cheap entertainment, there are some good folks over on this board, Risk and OS are my favorite and a few in between, they have never disrespected
AFFU
Horseb4CarT Horseb4CarT 20 분 전
DALE E. HO, United States District Judge:
On April 23, 2024, this Court issued an Opinion and Order dismissing Plaintiff
Phunware, Inc.’s Complaint for failure to adequately plead loss causation. See Opinion and
Order (“Order”) at 13-16, ECF No. 30. The parties’ familiarity with
PHUN UBS
nowwhat2 nowwhat2 22 분 전
https://investorshub.advfn.com/uimage/uploads/2024/11/26/tj[[ebtc_111111_26_30d_833pm_CHAN_KEY_W_XRP.jpg

Begging the question : Just WHEN might the 100,000 get revisited ?.....Soon, or could it take a while ?....January 20th ?



Likewise / similarily - Th
chereb19 chereb19 22 분 전
He's in your head, not the other way round.

https://investorshub.advfn.com/uimage/uploads/2024/3/7/dgoetDRK.JPG
RDGL
jondoeuk jondoeuk 23 분 전
This will be interesting, but we know that cancer cells are able to develop multiple mechanisms that enable the evasion of NKs. These mechanisms are likely the reason why NK based therapies show only limited success in clinic trials. Here is just one mechanism (that was recently found) https://www.c
IBRX
chereb19 chereb19 24 분 전
Dr. Mike Korenko stated “We are pleased with the FDA’s decision to grant Breakthrough Device Designation following our recent data submissions.
RDGL

최근 히스토리

LSE
GENF
Genflow Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유